Soham Mukherjee1, Mahon L Maguire1, Jack Sharkey1, Sourav Bhaduri1, Patricia Murray2, Rachel Bearon3, Bettina Wilm2, and Harish Poptani1
1Centre for Preclinical Imaging, University of Liverpool, Liverpool, United Kingdom, 2Department of Cellular and Molecular Physiology, University of Liverpool, Liverpool, United Kingdom, 3Department of Mathematical Sciences, University of Liverpool, Liverpool, United Kingdom
Synopsis
Quantitative analysis of kidney function is essential part of monitoring disease progression. The most common parameter of evaluating kidney functioning is by measurement of glomerular filtration rate. Here, we describe that dynamic contrast enhanced magnetic resonance imaging can be used to determine the permeability parameter Ktrans, which can be used to assess renal activity. We used three different pharmacokinetic models and arterial input functions to get the Ktrans value. It was seen that the raw arterial input function used along with shutter speed model has strong correlation with findings obtained from transcutaneous GFR measurement device.
Introduction
A key function of the kidney is to excrete waste and excess fluid. The
nephron is responsible for filtration in the kidney and is comprised of the glomerulus
across which ultrafiltration occurs. The current gold standard for measuring kidney
function is by estimation of the glomerular filtration rate (GFR) using inulin
or chromium ethylenediaminetetraacetic acid (Cr-EDTA) clearance rate measured
from serial blood samples. However, this invasive and time consuming procedure
provides no spatial information about organ function within the kidney 1. Several alternative non-invasive approaches have been established
including preclinical transcutaneous measurements of GFR which are based on the
elimination kinetics of fluorescent exogenous markers 2,3. However, these assays only provide a global GFR value and do not provide
any spatial information about the kidney. DCE data from the kidney can be
analysed using pharmacokinetic (PK) models to estimate GFR 4 , however, the application of these to murine models of kidney
disorders is not common and also these models lack the reproducibility required
for clinical application 5. Mouse kidney
DCE-MRI poses challenges due to respiratory motion, difficulty in measuring the
arterial input function (AIF), and accumulation of contrast agent in the renal pelvis
resulting in fast T2* relaxation and consequent signal loss. With
several competing PK models in use, it is not evident as to which model is most
appropriate for analysis of renal DCE data. In this study we compared three commonly used PK models: non-linear Tofts ; extended Tofts; and the shutter speed model (SSM). These models
have been used in brain tumours 6-8. While non-linear Tofts is computationally less taxing, it has precision
and fitting accuracy 8. Extended Tofts improves upon the non-linear model but is inconsistent for high temporal resolution data 9. SSM takes into consideration the transcytolemmal water exchange which
plays an important role in kidney function10. The parameter Ktrans is a transfer coefficient estimating the capillary permeability rate. Ktrans
multiplied by the kidney volume is typically used to compute GFR.Methods
Wild-type female C57BL/6 mice (n=9) were anaesthetized using 1.5-2.0%
isoflurane in oxygen. MR measurements were carried out on a 9.4 T scanner using
an 86 mm birdcage transmit coil and 4-channel receive array (Bruker, Germany). Mean T1 values of the kidney cortex
were measured using an inversion recovery pulse sequence. A catheter (30G
needle with poly-ethylene tubing) was inserted into the tail vein and filled
with heparin solution. A bolus of Gd-BOPTA (Multihance, Bracco Diagnostic Inc.,
Italy) was injected through the catheter (50 µl, 0.1 mmol/kg). A single slice, dual-echo gradient echo sequence was
used for DCE imaging (TR/TE1/TE2=15.43/1.26/6.99 ms, 25° flip angle, 192x96 matrix, 40x20 mm FOV, 987 ms temporal
resolution). Mean kidney volume was calculated from
multi-slice T2-weighted images for GFR measurements. DCE-MR images were processed off-line using
in-house software written in Matlab (Mathworks, USA). As the AIF is critical
to quantitative analysis of DCE data and is difficult to measure in mice, three
methods of estimating AIF were tested and their effects on PK model parameters
was assessed. AIF was estimated using the raw data, a singular spectrum
analysis (SSA) denoising algorithm11 and
a fitted bi-exponential curve. For parametric model analysis and parameter
extraction, Ktrans derived from non-linear, extended Tofts and SSM
were used, while for τi values, SSM was used using a non-linear
least-squares fitting based Levenberg-Marquardt algorithm. Initial fitting parameter values were selected based on literature 10,12.Results
Figure 1 shows three representative Ktrans maps from a left
renal cortex overlaid on a corresponding anatomical image; the maps were
generated using the three PK models and the AIF derived from the raw imaging
data. The boxplots in Figure 2 demonstrate the mean Ktrans values from
the nine mice measured for the three PK models and the three AIF models used. A significant difference in the Ktrans value (p<.05,
Figure 2) was observed using the extended Tofts model when compared with the
other models, while using the denoised AIF. On the other hand, Ktrans using the original
and the biexponential fitted AIF had no significant difference on the measured
Ktrans values using the three models. Ktrans estimated using
the AIF derived from the raw data demonstrated the least variability. Discussion
The GFR values derived from Ktrans estimated using the SSM (1416 ±
189 µl. min-1 100 g body wt-1) were matching the GFR values from the literature (1381 ± 264 µl min-1 100 g body wt-1) 2, whilst the Ktrans from the non-linear and extended
Tofts underestimated the GFR values indicating that SSM is the most
appropriate model under these experimental conditions. In addition, SSM estimates the value of τi providing a window into cellular
metabolism. The SSM-derived τi value was found to be very low which is shown in the voxel-wise analysis of the cortex of the
kidney as seen in figure 3.Conclusion
These results demonstrate that using the AIF derived from the raw
data along with SSM provides a consistent and accurate estimate of Ktrans
from the mouse kidney. Ktrans promises to be a useful measure of
renal function and GFR, thus enabling localised assessment of renal function in
the presence of heterogeneous/focal kidney injury, such as the ischemia-reperfusion
injury. Acknowledgements
This project has received funding from the European Union’s Horizon
2020 research and innovation programme under the Marie Skłodowska-Curie grant
agreement No 813839.References
1. G. Granerus and M. Aurell, “Reference
values for 51Cr-EDTA clearance as a measure of glomerular filtration rate,” Scand.
J. Clin. Lab. Invest., vol. 41, no. 6, pp. 611–616, Jan. 1981.
2. A. Schreiber et al.,
“Transcutaneous measurement of renal function in conscious mice,” Am. J.
Physiol. Physiol., vol. 303, no. 5, pp. F783–F788, Jun. 2012.
3. A. R. Poreddy et al., “Exogenous
fluorescent tracer agents based on pegylated pyrazine dyes for real-time
point-of-care measurement of glomerular filtration rate,” Bioorg. Med. Chem.,
vol. 20, no. 8, pp. 2490–2497, 2012.
4. S. P. Sourbron, H. J. Michaely, M. F.
Reiser, and S. O. Schoenberg, “MRI-Measurement of Perfusion and Glomerular
Filtration in the Human Kidney With a Separable Compartment Model,” Invest.
Radiol., vol. 43, no. 1, 2008.
5. I. Mendichovszky et al., “How
accurate is dynamic contrast-enhanced MRI in the assessment of renal glomerular
filtration rate? A critical appraisal,” J. Magn. Reson. Imaging, vol.
27, no. 4, pp. 925–931, 2008.
6. A. Bhandari, A. Bansal, A. Singh, and N.
Sinha, “Perfusion kinetics in human brain tumor with DCE-MRI derived model and
CFD analysis,” J. Biomech., vol. 59, pp. 80–89, 2017.
7. E. Szychot et al., “New trial of
convection enhanced drug delivery (CED) in DIPG- applying the SIOPe DIPG
survival prediction model for power calculation.,” Neuro. Oncol., vol.
21, no. Supplement_4, pp. iv11–iv11, Oct. 2019.
8. J. F. Kallehauge, S. Sourbron, B.
Irving, K. Tanderup, J. A. Schnabel, and M. A. Chappell, “Comparison of linear
and nonlinear implementation of the compartmental tissue uptake model for
dynamic contrast-enhanced MRI,” Magn. Reson. Med., vol. 77, no. 6, pp.
2414–2423, Jun. 2017.
9. S. B. Donaldson et al., “A
comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced
MRI: application in carcinoma of the
cervix.,” Magn. Reson. Med., vol. 63, no. 3, pp. 691–700, Mar. 2010.
10. M. Inglese et al., “Reliability of
dynamic contrast-enhanced magnetic resonance imaging data in primary brain
tumours: a comparison of Tofts and shutter speed models,” Neuroradiology,
vol. 61, no. 12, pp. 1375–1386, 2019.
11. R. Vautard and M. Ghil, “Singular spectrum
analysis in nonlinear dynamics, with applications to paleoclimatic time series,”
Phys. D Nonlinear Phenom., vol. 35, no. 3, pp. 395–424, 1989.
12. X. Li, W. D. Rooney, and C. S. Springer
Jr., “A unified magnetic resonance imaging pharmacokinetic theory:
Intravascular and extracellular contrast reagents,” Magn. Reson. Med.,
vol. 54, no. 6, pp. 1351–1359, Dec. 2005.